Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

What is Monogastric Digestion?01:50

What is Monogastric Digestion?

76.0K
The human body contains a monogastric digestive system. In a monogastric digestive system, the stomach only contains one chamber in which it digests food. Several other animal species also have monogastric digestive systems, including pigs, horses, dogs, and birds. This chapter, however, focuses on the human digestive system.
76.0K
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

731
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
731

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biovigilance in Faecal Microbiota Transplantation: 7-Year Cohort Study and Framework for Microbiological Assessments of Infectious Adverse Events.

United European gastroenterology journal·2026
Same author

Experimental human colonisation with non-toxigenic Clostridioides difficile: a placebo-controlled randomised clinical trial.

Nature communications·2026
Same author

Increase of <i>Clostridioides difficile</i> PCR ribotype 002 infection with decreased disease severity in hospitalized patients in the Netherlands.

Microbiology spectrum·2025
Same author

Metagenomic global survey and in-depth genomic analyses of Ruminococcus gnavus reveal differences across host lifestyle and health status.

Nature communications·2025
Same author

Innovating Thiopurine Therapeutic Drug Monitoring: A Systematic Review and Meta-Analysis on DNA-Thioguanine Nucleotides (DNA-TG) as an Inclusive Biomarker in Thiopurine Therapy.

Clinical pharmacokinetics·2024
Same author

The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridioides difficile infection and other potential indications: second edition of joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.

The Journal of hospital infection·2024

Related Experiment Video

Updated: Feb 20, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K

[Faecal microbiota transplantation: indications in perspective].

Y H van Beurden1, E M Terveer, J J Keller

  • 1VU medisch centrum, Amsterdam.

Nederlands Tijdschrift Voor Geneeskunde
|October 28, 2017
PubMed
Summary

Faecal microbiota transplantation (FMT) is a proven treatment for recurrent Clostridium difficile infection. Emerging research shows FMT

More Related Videos

Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.7K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Related Experiment Videos

Last Updated: Feb 20, 2026

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model
05:41

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

3.5K
Murine Fecal Isolation and Microbiota Transplantation
07:32

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

5.7K
Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

27.8K

Area of Science:

  • Gastroenterology and Microbiology
  • Microbiome Therapeutics

Background:

  • Recurrent Clostridium difficile infection (CDI) has limited treatment options.
  • Faecal microbiota transplantation (FMT) is established for recurrent CDI with high cure rates.
  • The efficacy of FMT for other gastrointestinal and systemic conditions is under investigation.

Purpose of the Study:

  • To review the current indications and emerging applications of FMT.
  • To summarize the effectiveness of FMT in ulcerative colitis and metabolic syndrome.
  • To highlight areas for future research in FMT.

Main Methods:

  • Review of existing literature on FMT.
  • Analysis of clinical trial data for FMT in various conditions.
  • Identification of patient subgroups and donor characteristics.

Main Results:

  • FMT achieves high cure rates (around 85%) for recurrent CDI.
  • FMT shows significant clinical and endoscopic improvement in ulcerative colitis patients (24-30%) compared to placebo.
  • FMT may improve insulin sensitivity in metabolic syndrome but does not affect weight or BMI.
  • FMT is being explored for Crohn's disease, irritable bowel syndrome, graft-versus-host-disease, and multidrug-resistant organism carriage.

Conclusions:

  • FMT is a definitive treatment for recurrent CDI.
  • FMT demonstrates promise for ulcerative colitis and metabolic syndrome.
  • Further randomized controlled trials are needed to establish FMT efficacy for other emerging indications.